LRPAP1 anticorps

N° du produit ABIN4956531

Cet anticorps anti-LRPAP1 est un anticorps Lapin Polyclonal détectant LRPAP1 dans WB, IHC et LBA. Adapté pour Humain.

Aperçu rapide pour LRPAP1 anticorps (ABIN4956531)

Antigène: LRPAP1 (Low Density Lipoprotein Receptor-Related Protein Associated Protein 1 (LRPAP1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LRPAP1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Ligand Binding Assay (LBA)

Détail du produit anti-LRPAP1 anticorps

Réactivité croisée: Poulet, Humain, Rat (Rattus)

Immunogène: recombinant human RAP

Information d'application

Indications d'application: Dilution: 1:50 - 1:100 (WB)

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: serum

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C/-20 °C

Détails sur LRPAP1

Antigène: LRPAP1 (Low Density Lipoprotein Receptor-Related Protein Associated Protein 1 (LRPAP1))

Autre désignation: RAP

Sujet: The antibody binds to an epitope of the C-terminal part of RAP, a sequence common to the human VLDL receptor superfamily (glycoprotein 330 and LRP), the chicken oocyte receptor for VLDL and vitellogenin (LR8), and glycoprotein 330/megalin from rat. No reaction with LDL receptor. The antibody interferes with binding of VLDL and vitellogenin receptor. Binding is Ca2+-dependent with LR8.